Skip to content
Paragon Biosciences LLC
  • About Us
  • Our Approach
  • Portfolio
  • Leadership
  • Careers
  • Contact Us
  • News Room

comms@paragonbiosci.com

61 items

  • May 13, 2019

    Jeff Aronin Receives Northern Illinois University’s 2019 Innovation and Entrepreneurship Award

    Jeff Aronin receives Northern Illinois University’s 2019 Innovation [...]

  • April 22, 2019

    Paragon Biosciences Names James Robinson President and Chief Operating Officer

    The newly-created position is the result of rapid [...]

  • December 3, 2018

    Jeff Aronin is Named Innovator of the Year by Best in Biz

    With its highest honor, a Gold level [...]

  • October 19, 2018

    Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle Creek Pharma

    Paragon organizes new investment from Fidelity Management [...]

  • October 19, 2018

    Crain’s Chicago Business: “Chicago-based Biotech Incubator Raises $71.8 Million”

    October 19, 2019 – Paragon Biosciences CEO Jeff Aronin [...]

  • October 1, 2018

    Jeff Aronin Named One of the 20 Most Influential Leaders in Healthcare for 2018

    Paragon CEO Jeff Aronin Recognized by Insights Care [...]

  • August 21, 2018

    Paragon Biosciences Announces Skyline Biosciences as the Newest Addition to Its Growing Portfolio of Companies

    CHICAGO – August 21, 2018 – Paragon Biosciences [...]

  • August 14, 2018

    Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome

    CHICAGO – August 14, 2018 – Biopharmaceutical company [...]

Previous678Next

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611 |

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611

© 2026 Paragon Biosciences LLC
Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500
Chicago, IL 60611

Page load link
Go to Top